Home › Funds › DEAN INVESTMENT ASSOCIATES, LLC › DGX

DEAN INVESTMENT ASSOCIATES, LLC position in DGX

QUEST DIAGNOSTICS INC · Health Care

DEAN INVESTMENT ASSOCIATES, LLC reported holding 24,891 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 0.83% of its reported portfolio and ranking #31 among its reported holdings. DEAN INVESTMENT ASSOCIATES, LLC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)24.89K sh
Reported value held$5.80M
Portfolio Weight0.83%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How DEAN INVESTMENT ASSOCIATES, LLC's DGX position evolved

DEAN INVESTMENT ASSOCIATES, LLC first disclosed a stake in DGX in Q3 2023 at 11,636 shares (US$1.4M). The position peaked in Q3 2026 at 24,891 shares, worth US$5.8M. Across 13 filings, DEAN INVESTMENT ASSOCIATES, LLC increased the stake 10 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 24,891 shares valued at US$5.8M — a reduction of -253 shares quarter over quarter.. Notable position changes include a 42% increase in Q4 2023 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 11.64K $1.42M New
Q4 2023 16.53K $2.28M Add
Q1 2024 16.70K $2.22M Add
Q2 2024 20.10K $2.75M Add
Q3 2024 19.51K $3.03M Reduce
Q4 2024 20.39K $3.08M Add
Q1 2025 21.11K $3.57M Add
Q2 2025 22.18K $3.98M Add
Q3 2025 23.65K $4.51M Add
Q4 2025 24.27K $4.21M Add
Q1 2026 24.65K $4.83M Add
Q2 2026 25.14K $5.33M Add
Q3 2026 24.89K $5.80M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 24 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.08B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$449.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has DEAN INVESTMENT ASSOCIATES, LLC held DGX?

DEAN INVESTMENT ASSOCIATES, LLC has disclosed DGX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is DEAN INVESTMENT ASSOCIATES, LLC's current position in DGX?

As of Q3 2026, DEAN INVESTMENT ASSOCIATES, LLC holds 24.89K shares of DGX (QUEST DIAGNOSTICS INC), valued at $5.80M, representing 0.83% of its reported portfolio and ranking #31.

Has DEAN INVESTMENT ASSOCIATES, LLC been buying or selling DGX?

In the latest 13F filing (Q3 2026), DEAN INVESTMENT ASSOCIATES, LLC reduced its position in DGX. The position peaked in Q3 2026 at 24.89K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.